A Study About the Safety of ASP2767 and Whether it Helps People With Glaucoma-Related Optic Nerve Damage
Clinical trial NCT07770685 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07770685
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-31
- Primary completion
- 2030-07-31
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.